Prostate cancer (PCa) is the most commonly diagnosed malignancy in male. Numerous
studies have focused on the molecular mechanisms of carcinogenesis and progression …

Epidermal growth factor receptor (EGFR) is a key oncogene in lung adenocarcinoma
(LUAD). Resistance to EGFR tyrosine kinase inhibitors is a major obstacle for EGFR-mutant …

Patients with non-small-cell lung cancer (NSCLC) have a low survival rate. Long non-coding
RNA (LncRNA) LANCL1 antisense RNA 1 (LANCL1-AS1) was indicated to be …

Background Castration-resistant prostate cancer (CRPC) is the lethal phenotype of prostate
cancer. Lipocalin 2 (LCN2) is aberrantly expressed in many cancers including primary …

OBJECTIVE: LINC00460 has been confirmed to contribute to cancer development.
However, the role and function of LINC00460 in prostate cancer is not identified. The …

The development of prostate cancer (PCa) from androgen-deprivation therapy (ADT)
sensitive to castration resistant (CRPC) seriously impacts life quality and survival of PCa …

Prostate cancer (PCa) growth and progression are uniquely dependent on androgens,
making the androgen receptor pathway a prime target for therapy; however, cancer …

Background Long non‐coding RNA differentiation antagonizing non‐protein coding RNA
(DANCR) acts as an oncogene in different cancers, although its roles in prostate cancer are …

Abstract BACKGROUND Lipocalin‐2 (LCN2) is a member of the lipocalin superfamily, and it
has an important role in the regulation of cellular oncogenesis and apoptosis. However, the …

Long non-coding RNA (LncRNA) LINC00160 was reported to be associated with cancer
progression and mediates drug resistance. However, the role of LINC00160 in prostate …